From: Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
n = 14
Pre-infusion
Post-infusion
% Change
P*
LVEF (%)
25 ± 3
31 ± 3
+31 ± 10
0.006
BNP (pg/ml)
859 ± 140
475 ± 111
-35 ± 11%
0.004